BioCatalystFeed / Readout calendar / FDA decisions / Drugs / Disease areas / Companies / Months
Catalysts by month
Archive from 2023-09. Each month lists industry Phase 2/3 primary completion dates and FDA decision events.
- 2028-01 - 0 readout(s), 1 FDA event(s)
- 2027-12 - 0 readout(s), 0 FDA event(s)
- 2027-11 - 0 readout(s), 0 FDA event(s)
- 2027-10 - 0 readout(s), 0 FDA event(s)
- 2027-09 - 0 readout(s), 0 FDA event(s)
- 2027-08 - 0 readout(s), 0 FDA event(s)
- 2027-07 - 0 readout(s), 0 FDA event(s)
- 2027-06 - 0 readout(s), 2 FDA event(s)
- 2027-05 - 0 readout(s), 2 FDA event(s)
- 2027-04 - 0 readout(s), 2 FDA event(s)
- 2027-03 - 0 readout(s), 4 FDA event(s)
- 2027-02 - 126 readout(s), 3 FDA event(s)
- 2027-01 - 167 readout(s), 3 FDA event(s)
- 2026-12 - 557 readout(s), 4 FDA event(s)
- 2026-11 - 189 readout(s), 20 FDA event(s)
- 2026-10 - 220 readout(s), 44 FDA event(s)
- 2026-09 - 221 readout(s), 38 FDA event(s)
- 2026-08 - 169 readout(s), 32 FDA event(s)
- 2026-07 - 194 readout(s), 48 FDA event(s)
- 2026-06 - 255 readout(s), 40 FDA event(s)
- 2026-05 - 177 readout(s), 39 FDA event(s)
- 2026-04 - 174 readout(s), 33 FDA event(s)
- 2026-03 - 180 readout(s), 33 FDA event(s)
- 2026-02 - 155 readout(s), 42 FDA event(s)
- 2026-01 - 182 readout(s), 20 FDA event(s)
- 2025-12 - 321 readout(s), 51 FDA event(s)
- 2025-11 - 180 readout(s), 37 FDA event(s)
- 2025-10 - 211 readout(s), 61 FDA event(s)
- 2025-09 - 206 readout(s), 31 FDA event(s)
- 2025-08 - 189 readout(s), 34 FDA event(s)
- 2025-07 - 196 readout(s), 42 FDA event(s)
- 2025-06 - 225 readout(s), 45 FDA event(s)
- 2025-05 - 211 readout(s), 35 FDA event(s)
- 2025-04 - 190 readout(s), 55 FDA event(s)
- 2025-03 - 185 readout(s), 42 FDA event(s)
- 2025-02 - 141 readout(s), 32 FDA event(s)
- 2025-01 - 193 readout(s), 29 FDA event(s)
- 2024-12 - 308 readout(s), 51 FDA event(s)
- 2024-11 - 212 readout(s), 32 FDA event(s)
- 2024-10 - 216 readout(s), 38 FDA event(s)
- 2024-09 - 195 readout(s), 48 FDA event(s)
- 2024-08 - 204 readout(s), 40 FDA event(s)
- 2024-07 - 185 readout(s), 29 FDA event(s)
- 2024-06 - 205 readout(s), 53 FDA event(s)
- 2024-05 - 212 readout(s), 22 FDA event(s)
- 2024-04 - 185 readout(s), 47 FDA event(s)
- 2024-03 - 191 readout(s), 56 FDA event(s)
- 2024-02 - 167 readout(s), 23 FDA event(s)
- 2024-01 - 169 readout(s), 23 FDA event(s)
- 2023-12 - 297 readout(s), 28 FDA event(s)
- 2023-11 - 228 readout(s), 23 FDA event(s)
- 2023-10 - 216 readout(s), 44 FDA event(s)
- 2023-09 - 185 readout(s), 35 FDA event(s)
Readout = ClinicalTrials.gov primary completion date (sponsor-reported; est. dates often slip; top-line
results usually follow weeks to months later). FDA events: PDUFA dates are extracted from company 8-K filings (SEC EDGAR) and are
company-disclosed and UNVERIFIED - read the filing; AdCom meetings come from Federal Register notices; approvals from Drugs@FDA
(openFDA); complete response letters from openFDA (published with a lag). Tickers are matched by name with a confidence score.
Generated 2026-11-18T17:57:33Z. Same data: bcf readouts search, bcf fda-decisions search, MCP
readout_calendar / fda_decisions. Not investment advice.